Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.

Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Abstract Text:

    b m wolpinB M Wolpin,d s michaudD S Michaud,e l giovannucciE L Giovannucci,e s schernhammerE S Schernhammer,m j stampferM J Stampfer,j e mansonJ E Manson,b b cochraneB B Cochrane,t e rohanT E Rohan,j maJ Ma,m n pollakM N Pollak,c s fuchsC S Fuchs,

    Insulin-like growth factor (IGF)-I induces growth in pancreatic cancer cells and blockade of the IGF-I receptor has antitumour activity. The association of plasma IGF-I and IGF binding protein-3 (IGFBP-3) with pancreatic cancer risk has been investigated in two small studies, with conflicting results. We conducted a nested case-control study within four large, prospective cohorts to investigate whether prediagnostic plasma levels of IGF-I, IGF-II, and IGFBP-3 were associated with pancreatic cancer risk. Plasma levels in 212 cases and 635 matched controls were compared by conditional logistic regression, with adjustment for other known pancreatic cancer risk factors. No association was observed between plasma levels of IGF-I, IGF-II, or IGFBP-3 and incident diagnosis of pancreatic cancer. Relative risks for the highest vs the lowest quartile of IGF-I, IGF-II, and IGFBP-3 were 0.94 (95% confidence interval (CI), 0.60-1.48), 0.96 (95% CI, 0.61-1.52), and 1.21 (95% CI, 0.75-1.92), respectively. The relative risk for the molar ratio of IGF-I and IGFBP-3, a surrogate measure for free IGF-I, was 0.84 (95% CI, 0.54-1.31). Additionally, no association was noted in stratified analyses or when requiring longer follow-up. In four prospective cohorts, we found no association between the risk of pancreatic cancer and prediagnostic plasma levels of IGF-I, IGF-II, or IGFBP-3.

    Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Publishing Authors By Initials

    bm wolpinBM Wolpin,ds michaudDS Michaud,el giovannucciEL Giovannucci,es schernhammerES Schernhammer,mj stampferMJ Stampfer,je mansonJE Manson,bb cochraneBB Cochrane,te rohanTE Rohan,j maJ Ma,mn pollakMN Pollak,cs fuchsCS Fuchs,

    For similar investigative techniques: epidemiologic methods: statistics as topic: probability: risk: risk factors research abstracts see: investigative techniques: epidemiologic methods: statistics as topic: probability: risk: risk factors research

    PUBMED ID PMID:

    MEDLINE DATE:

    Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: British journal of cancer

    VOLUME: 97

    Page Numbers: 98-104

    Journal Abbreviation: Br. J. Cancer

    ISSN: 0007-0920

    DAY: 29

    MONTH: 05

    YEAR: 2007

    Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 370635

    Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Keywords Mesh Terms:

    KEYWORDS: Risk Factors

    MESH TERMS: blood

    Chemical & Substance for Abstract: Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Information

    Substance Name: Insulin-Like Growth Factor II

    Registry Number: 67763-97-7

    Grant and Affiliation Information for Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.

    AFFILIATION: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. bwolpin@partners.org

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NCI

    GRANT: CA95589

    ACRONYM: CA

    MEDLINETA: Br J Cancer

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News